幹細胞の世界市場レポート 2024

幹細胞の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には10.8%の年間複合成長率（CAGR）で231億3,000万米ドルに成長すると予想されます。予測期間の成長は、臨床試験と規制当局の承認の進展に加え、腫瘍学における応用の増加、個別化医療の進歩、政府の取り組みからの支援と資金提供、バイオテクノロジーにおける共同の取り組みとパートナーシップに起因すると考えられます。予測期間の主な動向には、幹細胞療法の商業化、CRISPRテクノロジーの利用、規制枠組みの開発、幹細胞調査への投資、エクソソーム治療薬への焦点が含まれます。

幹細胞市場は、世界中で慢性疾患の有病率が増加していることにより成長しています。病気の治療または予防に幹細胞を使用する幹細胞療法は広く応用されており、最も一般的に使用される方法は骨髄移植です。臍帯血からの幹細胞を利用する他の治療法も使用されています。現在、血液 幹細胞の移植は、血液および免疫系に関連する疾患や状態に対処するため、または特定のがんの治療後に血液系を回復するために広く採用されています。たとえば、国立バイオテクノロジー情報センター（NCBI）による2023年 1月の報告書では、世界の慢性疾患患者の数は2020年の7,152万2,000人から2050年までに1億4,266万人に増加すると予測されています。

幹細胞市場の成長は、個別化医療に対する需要の高まりによってさらに加速されています。個別化医療は、個人の固有の遺伝子構造に合わせて医療を調整し、より正確で効果的なヘルスケア介入を提供します。個別化医療の文脈における幹細胞は、損傷した組織の再生と置換の可能性を提供し、個々の患者に合わせた治療を可能にします。 2022年、食品医薬品局の医薬品評価研究センター（CDER）は37の新しい分子実体（NME）を承認し、そのうち約34％（そのうち12）は個別化医療連合（PMC）によって個別化医療として分類されました。したがって、個別化医療に対する需要の高まりは、幹細胞市場の成長に貢献します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の幹細胞市場、由来別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 自己由来
• 同種異系
• 世界の幹細胞市場、製品タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 成人幹細胞
• ヒト胚性幹細胞
• 人工多能性幹細胞
• その他の製品
• 世界の幹細胞市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 再生医療
• 創薬と開発

第7章 地域および国の分析

• 世界の幹細胞市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の幹細胞市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 幹細胞市場の競合情勢
• 幹細胞市場の企業プロファイル
  • Danaher Corporation
  • Cryo-Cell International Inc.
  • Daiichi Sankyo Company Limited
  • Lonza Group Ltd
  • PerkinElmer Inc.

第31章 その他の大手および革新的な企業

• CellGenix GmbH
• China Cord Blood Corporation
• Organogenesis Holdings Inc.
• LifeCell International
• AMAG Pharmaceuticals Inc.
• Cord Blood America Inc.
• StemCyte Inc.
• Cryoviva India
• Cordlife Group Limited
• Thermo Fisher Scientific Inc.
• CordVida
• Cryo Stemcell Inc.
• Pluristem Therapeutics Inc.
• Mesoblast Limited
• Americord Registry LLC

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Stem cells, whether autologous or allogenic, possess the ability to differentiate into various cell types both in vivo and in vitro, making them valuable in the medical treatment of injuries and organ damage.

The primary product categories of stem cells include adult stem cells, human embryonic stem cells, induced pluripotent stem cells, and others. Adult stem cells represent a rare cell population in the body during the majority of postnatal life, capable of giving rise to a limited number of mature cell types that contribute to the formation of the tissue in which they are located. These stem cells can be derived from autologous or allogeneic sources and find applications in diverse areas such as regenerative medicine, drug discovery, and development.

The stem cell market research report is one of a series of new reports from The Business Research Company that provides stem cell market statistics, including stem cell market industry global market size, regional shares, competitors with a stem cell market share, detailed stem cell market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell market industry. This stem cell market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The stem cell market size has grown strongly in recent years. It will grow from $13.97 billion in 2023 to $15.34 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to progress in regenerative medicine, a rise in the prevalence of chronic diseases, ongoing research and development initiatives, an increasing aging population, and the heightened awareness and acceptance of stem cell technologies.

The stem cell market size is expected to see rapid growth in the next few years. It will grow to $23.13 billion in 2028 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to the increasing applications in oncology, advancements in personalized medicine, support and funding from government initiatives, collaborative efforts and partnerships in biotechnology, along with the progression of clinical trials and regulatory approvals. Major trends in the forecast period include the commercialization of stem cell therapies, the utilization of CRISPR technology, the development of regulatory frameworks, investments in stem cell research, and a focus on exosome therapeutics.

The Stem cell market is experiencing growth due to the increasing prevalence of chronic diseases worldwide. Stem-cell therapy, involving the use of stem cells to treat or prevent diseases, has seen widespread application, with bone marrow transplants being the most commonly used method. Other therapies utilizing stem cells from umbilical cord blood are also in use. Currently, the transplantation of blood stem cells is widely employed to address diseases and conditions related to the blood and immune system or to restore the blood system post-treatments for specific cancers. For example, a report from January 2023 by the National Center for Biotechnology Information (NCBI) projects that the global number of people with chronic diseases will increase from 71.522 million in 2020 to 142.66 million by 2050.

The growth of the stem cell market is further fueled by the increasing demand for personalized medicine. Personalized medicine tailors medical treatment to an individual's unique genetic makeup, providing more precise and effective healthcare interventions. Stem cells, in the context of personalized medicine, offer the potential for regenerating and replacing damaged tissues, allowing for treatments tailored to individual patients. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% (12 of them) classified as personalized medicines by the Personalized Medicine Coalition (PMC). Thus, the rising demand for personalized medicine contributes to the growth of the stem cell market.

The growth of the stem cell market is hindered by the low acceptance rate for stem cell therapy treatments, particularly in the field of Embryonic stem cell therapeutics. Many of these treatments remain unproven in clinical trials and are considered highly experimental. Due to the experimental nature of these therapies, patients are often hesitant to undergo such treatments due to potential health, personal, and financial risks. For instance, individuals undergoing unproven or experimental treatments might become ineligible for future clinical trials or alternative treatment options. An illustrative example is a case in the USA where three elderly women were blinded after receiving stem cells derived from fat tissue at a clinic in Florida. These factors contribute to the limited adoption of stem cell therapies, thereby restraining the overall growth of the stem cell market.

Companies operating in the stem cell therapeutics market are concentrating on advancing technologies, such as Induced Pluripotent Stem Cells (IPSC), to enhance the effectiveness of stem cell therapies. IPSCs are derived from blood or skin cells that undergo reprogramming to achieve an embryonic-such as pluripotent state. This process involves the introduction of genes essential for maintaining key properties and promoting the growth of an unlimited source of any human cell type required for stem cell therapeutic purposes. Importantly, IPSCs are not derived from human embryos, addressing bioethical concerns and facilitating easier access to federal funding and support. An illustrative example is the Japanese company Oksara, which inaugurated a medicine center producing cells derived from IPSCs. Similarly, Takar Bio introduced human iPSC-derived Beta Cells, known as Cellartis, designed for disease modeling and drug discovery.

Major companies in the stem cell market are also prioritizing the development of automated stem cell analysis systems to gain a competitive advantage. These systems streamline the assessment of stem cell characteristics and viability, enhancing research and clinical applications with increased efficiency and precision. For instance, in May 2022, Beckman Coulter Inc., a US-based healthcare company, launched the AQUIOS STEM System, a solution specifically engineered for stem cell analysis. This system offers full automation, reducing hands-on time by 95% and minimizing error-prone tasks by 87.5%. Combining the automation capabilities of the AQUIOS CL with a stem cell enumeration solution, it can be customized to meet diverse requirements.

In August 2021, Catalent, a US-based provider of advanced delivery technologies, acquired RheinCell Therapeutics GmbH for an undisclosed amount. This strategic acquisition aims to leverage RheinCell's expertise in iPSC cell lines to enhance Catalent's cell therapy portfolio, providing iPSC banks as a premium source for therapeutic development pathways to their customers. RheinCell Therapeutics GmbH, based in Germany, specializes in the GMP-compliant generation of human induced pluripotent stem cells (iPSCs).

Major companies operating in the stem cell market report are Danaher Corporation, Cryo-Cell International Inc., Daiichi Sankyo Company Limited, Lonza Group Ltd., PerkinElmer Inc., CellGenix GmbH, China Cord Blood Corporation, Organogenesis Holdings Inc., LifeCell International, AMAG Pharmaceuticals Inc., Cord Blood America Inc., StemCyte Inc., Cryoviva India, Cordlife Group Limited, Thermo Fisher Scientific Inc., CordVida, Cryo Stemcell Inc., Pluristem Therapeutics Inc., Mesoblast Limited, Americord Registry LLC, Smart Cells International, Athersys Inc., ReeLabs Pvt. Ltd., Cytori Therapeutics Inc., Esperite N.V., Stemade Biotech, ViaCord, Aldagen Inc., Isto Biologics, Brainstorm Cell Therapeutics Inc., Osiris Therapeutics Inc.

North America was the largest region in the stem cell market in 2023. Western Europe was the second largest region in the global stem cell market share. The regions covered in the stem cell market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the stem cell market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The stem cell market consists of sales of organoids & 3D Cell Culture, mesenchymal Stem Cells, neural stem cells, hematopoietic stem cells, and cancer stem cells. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Stem Cell Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on stem cell market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for stem cell ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The stem cell market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Source: Autologous; Allogeneic
• 2) By Product Type: Adult Stem Cell; Human Embryonic Stem Cell; Induced Pluripotent Stem Cell; Other Products
• 3) By Application: Regenerative Medicine; Drug Discovery And Development
• Companies Mentioned: Danaher Corporation; Cryo-Cell International Inc.; Daiichi Sankyo Company Limited; Lonza Group Ltd; PerkinElmer Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Stem Cell Market Characteristics

3. Stem Cell Market Trends And Strategies

4. Stem Cell Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Stem Cell Market Size and Growth

• 5.1. Global Stem Cell Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Stem Cell Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Stem Cell Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Stem Cell Market Segmentation

• 6.1. Global Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Autologous
• Allogeneic
• 6.2. Global Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Adult Stem Cell
• Human Embryonic Stem Cell
• Induced Pluripotent Stem Cell
• Other Products
• 6.3. Global Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Regenerative Medicine
• Drug Discovery And Development

7. Stem Cell Market Regional And Country Analysis

• 7.1. Global Stem Cell Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Stem Cell Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Stem Cell Market

• 8.1. Asia-Pacific Stem Cell Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Stem Cell Market

• 9.1. China Stem Cell Market Overview
• 9.2. China Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Stem Cell Market

• 10.1. India Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Stem Cell Market

• 11.1. Japan Stem Cell Market Overview
• 11.2. Japan Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Stem Cell Market

• 12.1. Australia Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Stem Cell Market

• 13.1. Indonesia Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Stem Cell Market

• 14.1. South Korea Stem Cell Market Overview
• 14.2. South Korea Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Stem Cell Market

• 15.1. Western Europe Stem Cell Market Overview
• 15.2. Western Europe Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Stem Cell Market

• 16.1. UK Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Stem Cell Market

• 17.1. Germany Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Stem Cell Market

• 18.1. France Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Stem Cell Market

• 19.1. Italy Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Stem Cell Market

• 20.1. Spain Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Stem Cell Market

• 21.1. Eastern Europe Stem Cell Market Overview
• 21.2. Eastern Europe Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Stem Cell Market

• 22.1. Russia Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Stem Cell Market

• 23.1. North America Stem Cell Market Overview
• 23.2. North America Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Stem Cell Market

• 24.1. USA Stem Cell Market Overview
• 24.2. USA Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Stem Cell Market

• 25.1. Canada Stem Cell Market Overview
• 25.2. Canada Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Stem Cell Market

• 26.1. South America Stem Cell Market Overview
• 26.2. South America Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Stem Cell Market

• 27.1. Brazil Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Stem Cell Market

• 28.1. Middle East Stem Cell Market Overview
• 28.2. Middle East Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Stem Cell Market

• 29.1. Africa Stem Cell Market Overview
• 29.2. Africa Stem Cell Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Stem Cell Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Stem Cell Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Stem Cell Market Competitive Landscape And Company Profiles

• 30.1. Stem Cell Market Competitive Landscape
• 30.2. Stem Cell Market Company Profiles
  • 30.2.1. Danaher Corporation
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Cryo-Cell International Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Daiichi Sankyo Company Limited
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Lonza Group Ltd
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. PerkinElmer Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Stem Cell Market Other Major And Innovative Companies

• 31.1. CellGenix GmbH
• 31.2. China Cord Blood Corporation
• 31.3. Organogenesis Holdings Inc.
• 31.4. LifeCell International
• 31.5. AMAG Pharmaceuticals Inc.
• 31.6. Cord Blood America Inc.
• 31.7. StemCyte Inc.
• 31.8. Cryoviva India
• 31.9. Cordlife Group Limited
• 31.10. Thermo Fisher Scientific Inc.
• 31.11. CordVida
• 31.12. Cryo Stemcell Inc.
• 31.13. Pluristem Therapeutics Inc.
• 31.14. Mesoblast Limited
• 31.15. Americord Registry LLC

32. Global Stem Cell Market Competitive Benchmarking

33. Global Stem Cell Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Stem Cell Market

35. Stem Cell Market Future Outlook and Potential Analysis

• 35.1 Stem Cell Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Stem Cell Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Stem Cell Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer